Thus, the data suggest that low ISCA2 levels in ccRCC are associated with pVHL loss and with poorer prognosis, and that cells lacking functional pVHL are more sensitive to ISCA2 inhibition, in part due to decreased ISCA2. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.